Authors: Goto, Hironobu¹ (AUTHOR), Oshikiri, Taro¹ (AUTHOR) oshikiri@med.kobe-u.ac.jp, Kato, Takashi¹ (AUTHOR), Nagatani, Yoshiaki² (AUTHOR), Funakoshi, Yohei² (AUTHOR), Koterazawa, Yasufumi¹ (AUTHOR), Sawada, Ryuichiro¹ (AUTHOR), Harada, Hitoshi¹ (AUTHOR), Urakawa, Naoki¹ (AUTHOR), Hasegawa, Hiroshi¹ (AUTHOR), Kanaji, Shingo¹ (AUTHOR), Yamashita, Kimihiro¹ (AUTHOR), Matsuda, Takeru¹ (AUTHOR), Minami, Hironobu² (AUTHOR), Kakeji, Yoshihiro¹ (AUTHOR)

Superior Title: PLoS ONE. 4/18/2024, Vol. 19 Issue 4, p1-8. 8p.

Subject Terms: *NIVOLUMAB, *CISPLATIN, *IPILIMUMAB, *DOCETAXEL, *ADJUVANT chemotherapy, *ESOPHAGEAL cancer, *NEOADJUVANT chemotherapy, *CETUXIMAB

Geographic Terms: JAPAN

Authors: Elez, Elena¹ (AUTHOR) meelez@vhio.net, Cubillo, Antonio^2,3 (AUTHOR), Alfonso, Pilar Garcia⁴ (AUTHOR), Middleton, Mark R.⁵ (AUTHOR), Chau, Ian⁶ (AUTHOR), Alkuzweny, Baha⁷ (AUTHOR), Alcasid, Ann⁸ (AUTHOR), Zhang, Xiaosong⁹ (AUTHOR), Van Cutsem, Eric¹⁰ (AUTHOR)

Superior Title: BMC Cancer. 4/11/2024, Vol. 24 Issue 1, p1-10. 10p.

Subject Terms: *DNA mismatch repair, *NIVOLUMAB, *BRAF genes, *COLORECTAL cancer, *IMMUNE checkpoint inhibitors, *IPILIMUMAB, *METASTASIS

Authors: Hsu, Chiun^1,2 (AUTHOR) hsuchiun@ntu.edu.tw, Chang, Yi-Fang³ (AUTHOR), Yen, Chia-Jui⁴ (AUTHOR), Xu, Yu-Wei⁵ (AUTHOR), Dong, Min⁵ (AUTHOR), Tong, You-Zhi⁵ (AUTHOR)

Superior Title: BMC Medicine. 10/20/2023, Vol. 21 Issue 1, p1-11. 11p.

Subject Terms: *NIVOLUMAB, *MONOCLONAL antibodies, *ANTINEOPLASTIC agents, *PLATELET count, *PROGRESSION-free survival

Authors: Chen, Yen-Hao^1,2,3,4 (AUTHOR) alex8701125@gmail.com, Tsai, Ching-Hua⁵ (AUTHOR), Chen, Yen-Yang¹ (AUTHOR), Wang, Chih-Chi⁶ (AUTHOR), Wang, Jing-Houng⁷ (AUTHOR), Hung, Chao-Hung⁷ (AUTHOR), Kuo, Yuan-Hung⁷ (AUTHOR)

Superior Title: BMC Cancer. 8/29/2023, Vol. 23 Issue 1, p1-10. 10p.

Subject Terms: *NIVOLUMAB, *HEPATOCELLULAR carcinoma, *PEMBROLIZUMAB, *PROGNOSIS, *LIVER cancer

Authors: Nadal, Ernest¹ (AUTHOR) esnadal@iconcologia.net, Saleh, Mansoor² (AUTHOR), Aix, Santiago Ponce³ (AUTHOR), Ochoa-de-Olza, Maria⁴ (AUTHOR), Patel, Sandip Pravin⁵ (AUTHOR), Antonia, Scott⁶ (AUTHOR), Zhao, Yumin⁷ (AUTHOR), Gueorguieva, Ivelina⁷ (AUTHOR), Man, Michael⁷ (AUTHOR), Estrem, Shawn T.⁷ (AUTHOR), Liu, Jiangang⁷ (AUTHOR), Avsar, Emin^7,8 (AUTHOR), Lin, Wen Hong^8,9 (AUTHOR), Benhadji, Karim A.⁷ (AUTHOR), Gandhi, Leena^7,10 (AUTHOR), Guba, Susan C.⁷ (AUTHOR), Diaz, Inmaculada Ales¹¹ (AUTHOR)

Superior Title: BMC Cancer. 7/28/2023, Vol. 23 Issue 1, p1-13. 13p.

Subject Terms: *NON-small-cell lung carcinoma, *NIVOLUMAB, *TRANSFORMING growth factors, *INTERFERON gamma, *ADVERSE health care events

Authors: Cascone, T.¹ tcascone@mdanderson.org, Awad, M. M.², Spicer, J. D.³, He, J.⁴, Lu, S.⁵, Sepesi, B.¹, Tanaka, F.⁶, Taube, J. M.⁷, Cornelissen, R.⁸, Havel, L.⁹, Karaseva, N.¹⁰, Kuzdzal, J.¹¹, Petruzelka, L. B.¹², Wu, L.¹³, Pujol, J.-L.¹⁴, Ito, H.¹⁵, Ciuleanu, T.-E.¹⁶, de Oliveira Muniz Koch, L.¹⁷, Janssens, A.¹⁸, Alexandru, A.¹⁹

Superior Title: New England Journal of Medicine. 5/16/2024, Vol. 390 Issue 19, p1756-1769. 14p.

Subject Terms: *NIVOLUMAB, *LUNG cancer, *NEOADJUVANT chemotherapy, *NON-small-cell lung carcinoma, *ADVERSE health care events

Authors: Oaknin, Ana¹ (AUTHOR) aoaknin@vhio.net, Moore, Kathleen^2,3 (AUTHOR), Meyer, Tim⁴ (AUTHOR), López-Picazo González, José⁵ (AUTHOR), Devriese, Lot A⁶ (AUTHOR), Amin, Asim⁷ (AUTHOR), Lao, Christopher D⁸ (AUTHOR), Boni, Valentina⁹ (AUTHOR), Sharfman, William H¹⁰ (AUTHOR), Park, Jong Chul¹¹ (AUTHOR), Tahara, Makoto¹² (AUTHOR), Topalian, Suzanne L¹⁰ (AUTHOR), Magallanes, Manuel¹³ (AUTHOR), Molina Alavez, Alejandro¹⁴ (AUTHOR), Khan, Tariq Aziz¹⁵ (AUTHOR), Copigneaux, Catherine¹⁵ (AUTHOR), Lee, Michelle^15,16 (AUTHOR), Garnett-Benson, Charlie¹⁵ (AUTHOR), Wang, Xuya¹⁵ (AUTHOR), Naumann, R Wendel⁷ (AUTHOR)

Superior Title: Lancet Oncology. May2024, Vol. 25 Issue 5, p588-602. 15p.

Subject Terms: *INTERACTIVE voice response (Telecommunication), *NIVOLUMAB, *CERVICAL cancer, *METASTASIS, *IPILIMUMAB, *HYPONATREMIA, *SYNCOPE

Authors: El-Khoueiry, A.B.¹ (AUTHOR) elkhouei@usc.edu, Trojan, J.² (AUTHOR), Meyer, T.³ (AUTHOR), Yau, T.⁴ (AUTHOR), Melero, I.⁵ (AUTHOR), Kudo, M.⁶ (AUTHOR), Hsu, C.^7,8 (AUTHOR), Kim, T.-Y.⁹ (AUTHOR), Choo, S.-P.¹⁰ (AUTHOR), Kang, Y.-K.¹¹ (AUTHOR), Yeo, W.¹² (AUTHOR), Chopra, A.¹³ (AUTHOR), Soleymani, S.¹⁴ (AUTHOR), Yao, J.¹⁵ (AUTHOR), Neely, J.¹⁶ (AUTHOR), Tschaika, M.¹⁷ (AUTHOR), Welling, T.H.¹⁸ (AUTHOR), Sangro, B.¹⁹ (AUTHOR)

Superior Title: Annals of Oncology. Apr2024, Vol. 35 Issue 4, p381-391. 11p.

Subject Terms: *NIVOLUMAB, *ADVERSE health care events, *HEPATOCELLULAR carcinoma

Authors: Hsu, Ping-Chih^1,2 (AUTHOR), Chen, Tai-Di^2,3 (AUTHOR), Tsai, Tsung-Yu^3,4 (AUTHOR), Yang, Cheng-Ta^1,5,6 (AUTHOR) yang1946@cgmh.org.tw

Superior Title: Clinics & Practice. Feb2023, Vol. 13 Issue 1, p200-205. 6p.

Subject Terms: *BEVACIZUMAB, *NIVOLUMAB, *IMMUNE checkpoint inhibitors, *PACLITAXEL, *CARBOPLATIN

Alternate Title: Date de tip real world privind utilizarea nivolumabului în cancerul pulmonar nonmicrocelular avansat – dincolo de linia a doua. Experiența noastră în România imediat după rambursarea imunoterapiei prin sistemul național de sănătate.

Authors: Teodorescu, Mihaela¹ albu.mihaela.laura@gmail.com, Grigorescu, Alexandru C.²

Superior Title: Oncolog-Hematolog. 2023, Issue 62, p32-41. 10p.

Subject Terms: *NON-small-cell lung carcinoma, *NIVOLUMAB, *IMMUNE checkpoint inhibitors, *MEDICAL care costs, *REIMBURSEMENT

Geographic Terms: ROMANIA

Authors: Moser, Justin C.¹ (AUTHOR) jmoser@honorhealth.com, Bhatia, Shailender² (AUTHOR), Amin, Asim³ (AUTHOR), Pavlick, Anna C.⁴ (AUTHOR), Betts, Keith A.⁵ (AUTHOR), Du, Ella Xiaoyan⁵ (AUTHOR), Poretta, Tayla⁶ (AUTHOR), Shelley, Karishma⁶ (AUTHOR), Srinivasan, Swetha⁶ (AUTHOR), Sakkal, Leon Alan⁶ (AUTHOR), Palaia, Jennell⁶ (AUTHOR), Lobo, Maurice⁶ (AUTHOR), Pe Benito, Melanie⁶ (AUTHOR), Linton, Joshua A.⁶ (AUTHOR), Chen, Yan⁵ (AUTHOR), Xu, Churong⁵ (AUTHOR), Yin, Lei⁵ (AUTHOR), Sundar, Manasvi⁵ (AUTHOR), Weber, Jeffrey⁷ (AUTHOR)

Superior Title: Cancer Immunology, Immunotherapy. Jul2024, Vol. 73 Issue 7, p1-12. 12p.

Subject Terms: *NIVOLUMAB, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *MELANOMA, *OVERALL survival

Authors: Maeda, Takuya¹ (AUTHOR), Yanagi, Teruki¹ (AUTHOR) yanagi@med.hokudai.ac.jp, Miyamoto, Kodai¹ (AUTHOR), Tokuchi, Keiko¹ (AUTHOR), Kitamura, Shinya¹ (AUTHOR), Ujiie, Hideyuki¹ (AUTHOR)

Superior Title: Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-4. 4p.

Subject Terms: *NIVOLUMAB, *PROGRESSION-free survival, *IMMUNE checkpoint inhibitors, *TYPE 1 diabetes, *ADVERSE health care events

Authors: Hamada, Kosuke¹ (AUTHOR), Fujiwara, Ryo¹ (AUTHOR) ryo.fujiwara@jfcr.or.jp, Takemura, Kosuke² (AUTHOR), Komai, Yoshinobu¹ (AUTHOR), Oguchi, Tomohiko¹ (AUTHOR), Numao, Noboru¹ (AUTHOR), Yamamoto, Shinya¹ (AUTHOR), Yonese, Junji¹ (AUTHOR), Yuasa, Takeshi¹ (AUTHOR)

Superior Title: International Journal of Urology. Oct2022, Vol. 29 Issue 10, p1181-1187. 7p.

Subject Terms: *NIVOLUMAB, *METASTASIS, *LYMPH nodes

Authors: S⊘by, Sebastian¹ (AUTHOR), Gothelf, Anita² (AUTHOR), Gyldenkerne, Niels³ (AUTHOR), Bentzen, Jens⁴ (AUTHOR), Andersen, Maria⁵ (AUTHOR), Tramm, Trine⁶ (AUTHOR), Eriksen, Jesper Grau¹ (AUTHOR)

Superior Title: Radiotherapy & Oncology. Mar2024:Supplement 1, Vol. 192, pS130-S133. 4p.

Subject Terms: *HEAD & neck cancer, *NIVOLUMAB, *PEMBROLIZUMAB, *TUMOR treatment, *CETUXIMAB, *SQUAMOUS cell carcinoma, *TREATMENT effectiveness

Authors: Hu, Zheyi¹ (AUTHOR), Liu, Sihang¹ (AUTHOR), Zhao, Yue¹ (AUTHOR), Du, Shengnan¹ (AUTHOR), Hamuro, Lora¹ (AUTHOR), Shen, Jun¹ (AUTHOR), Roy, Amit¹ (AUTHOR), Zhu, Li¹ (AUTHOR) li.zhu@bms.com

Superior Title: CPT: Pharmacometrics & Systems Pharmacology. Mar2024, Vol. 13 Issue 3, p476-493. 18p.

Subject Terms: *NIVOLUMAB, *CHILD patients, *IPILIMUMAB, *CHILDHOOD cancer, CENTRAL nervous system tumors

Authors: Juric, Dejan¹ (AUTHOR) juric.dejan@mgh.harvard.edu, Barve, Minal² (AUTHOR), Vaishampayan, Ulka³ (AUTHOR), Roda, Desamparados⁴ (AUTHOR), Calvo, Aitana⁵ (AUTHOR) aitanacalvo@hotmail.com, Jañez, Noelia Martinez⁶ (AUTHOR), Trigo, Jose⁷ (AUTHOR), Greystoke, Alastair⁸ (AUTHOR), Harvey, R. Donald⁹ (AUTHOR), Olszanski, Anthony J.¹⁰ (AUTHOR), Opyrchal, Mateusz¹¹ (AUTHOR), Spira, Alexander^12,13 (AUTHOR), Thistlethwaite, Fiona¹⁴ (AUTHOR), Jiménez, Begoña⁷ (AUTHOR), Sappal, Jessica Huck¹⁵ (AUTHOR), Kannan, Karuppiah¹⁶ (AUTHOR), Riley, Jason¹⁷ (AUTHOR), Li, Cheryl¹⁸ (AUTHOR), Li, Cong¹⁹ (AUTHOR), Gregory, Richard C.¹⁵ (AUTHOR)

Superior Title: Cancer Medicine. Mar2024, Vol. 13 Issue 5, p1-16. 16p.

Subject Terms: *NIVOLUMAB, *TRIPLE-negative breast cancer, *ASPARTATE aminotransferase, *CELL populations, *TUMORS

Authors: Takahiro Matsuyama¹ tak-matu@m2.kufm.kagoshima-u.ac.jp, Masashi Oniwa¹, Kentaro Tsuruzono¹, Shunsuke Yasuda¹, Mikiko Yone¹, Yuya Tomioka¹, Akifumi Uchida¹, Hideo Mitsuyama¹, Shingo Kubota¹, Takayuki Suetsugu¹, Keiko Mizuno¹, Hiromasa Inoue¹

Superior Title: Respirology Case Reports. Jan2024, Vol. 12 Issue 1, p1-4. 4p.

Subject Terms: *LITERATURE reviews, *NIVOLUMAB, *VISUAL acuity, *IPILIMUMAB, *LYMPHATIC metastasis, *POLYPOIDAL choroidal vasculopathy

Authors: Lee, Choong-kun^1,2 (AUTHOR), Lee, Jii Bum¹ (AUTHOR), Park, Se Jung² (AUTHOR), Che, Jingmin² (AUTHOR), Kwon, Woo Sun² (AUTHOR), Kim, Hyo Song^1,2 (AUTHOR), Jung, Minkyu^1,2 (AUTHOR), Lee, Seulkee³ (AUTHOR), Park, Sook Ryun⁴ (AUTHOR), Koo, Dong-Hoe⁵ (AUTHOR), Lee, Hyun Woo⁶ (AUTHOR), Bae, Woo Kyun⁷ (AUTHOR), Jeung, Hei-Cheul⁸ (AUTHOR), Hwang, In Gyu⁹ (AUTHOR), Kim, Hyunki¹⁰ (AUTHOR), Nam, Chung Mo¹¹ (AUTHOR), Chung, Hyun Cheol^1,2 (AUTHOR), Rha, Sun Young^1,2 (AUTHOR) RHA7655@yuhs.ac

Superior Title: Gastric Cancer. Jan2024, Vol. 27 Issue 1, p118-130. 13p.

Subject Terms: *NIVOLUMAB, *STOMACH cancer, *PACLITAXEL, *PATIENT selection, *INTERLEUKIN-1 receptors

Geographic Terms: SOUTH Korea

Authors: Du, Shengnan¹ (AUTHOR), Zhao, Yue¹ (AUTHOR), Hu, Zheyi¹ (AUTHOR), Liu, Sihang¹ (AUTHOR), Roy, Amit¹ (AUTHOR), Shen, Jun¹ (AUTHOR), Zhu, Li¹ (AUTHOR), Hamuro, Lora¹ (AUTHOR) lora.hamuro@bms.com

Superior Title: CPT: Pharmacometrics & Systems Pharmacology. Jan2024, Vol. 13 Issue 1, p168-179. 12p.

Subject Terms: *NIVOLUMAB, *IPILIMUMAB, *MELANOMA, *BODY weight, *TEENAGERS

Authors: Magalhães, César¹ (AUTHOR) cesar.magalhaes@chvng.min-saude.pt, Costa, Miguel¹ (AUTHOR), Campainha, Sérgio² (AUTHOR), Coelho, André³ (AUTHOR), César, Artur¹ (AUTHOR)

Superior Title: Journal of Cutaneous Pathology. Apr2023, Vol. 50 Issue 4, p298-300. 3p. 2 Color Photographs.

Subject Terms: *NIVOLUMAB, *DRUG side effects, *DRUG eruptions, *IMMUNE checkpoint proteins